Leiv Lea - 09 Sep 2021 Form 4 Insider Report for Corvus Pharmaceuticals, Inc. (CRVS)

Role
Chief Financial Officer
Signature
/s/ Leiv Lea
Issuer symbol
CRVS
Transactions as of
09 Sep 2021
Net transactions value
$0
Form type
4
Filing time
13 Sep 2021, 16:59:52 UTC
Next filing
17 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRVS Stock Option (Right to Buy) Award $0 +160,000 $0.000000 160,000 09 Sep 2021 Common Stock 160,000 $2.60 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The underlying shares subject to the option vest and become exercisable as to one-forty eighth (1/48th) of the shares subject to the option in successive, equal monthly installments measured from September 9, 2021, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.